# FDA Inspection 1052807 - Ranier's Compounding Laboratory - May 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/raniers-compounding-laboratory/288c59b1-e170-4b86-bbd8-3dadf83d24f3
Source feed: FDA_Inspections

> FDA Inspection 1052807 for Ranier's Compounding Laboratory on May 22, 2018. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052807
- Company Name: Ranier's Compounding Laboratory
- Inspection Date: 2018-05-22
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1148893 - 2021-08-16](https://www.keypedia.com/records/fda_inspections/raniers-compounding-laboratory/6ffce5ef-0234-4085-a1e8-d872563d3993)
- [FDA Inspection 1052807 - 2018-05-22](https://www.keypedia.com/records/fda_inspections/raniers-compounding-laboratory/594143bc-e9aa-4f65-b9d5-8959d6a08d5d)
- [FDA Inspection 975474 - 2016-04-22](https://www.keypedia.com/records/fda_inspections/raniers-compounding-laboratory/784c3aeb-1f37-4383-b76b-8d4d20127a76)

Company: https://www.keypedia.com/companies/raniers-compounding-laboratory/855db94e-37e1-43f0-af82-9ce0197e39f1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c